Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | NR1H4 | Q96RI1 | 6/20 | 0.57 |
| ▸ | SELP | P16109 | 2/20 | 0.56 |
| ▸ | SELE | P16581 | 2/20 | 0.56 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 5/20 | 0.53 |
| ▸ | PPARD | Q03181 | 5/20 | 0.53 |
| ▸ | PPARA | Q07869 | 5/20 | 0.53 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.52 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.52 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.52 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.52 |
| ▸ | SELL | P14151 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10756329 | 0.85 | ITGB3 (0.55) | L3MBTL1NR1H4SELPSELEPPARG | |
| SCHEMBL14041043 | 0.84 | L3MBTL1 (0.61) | L3MBTL1PDK1PDK2PDK3PDK4 | |
| SCHEMBL28182250 | 0.84 | PDK1 (0.71) | L3MBTL1PDK1PDK2PDK3PDK4 | |
| SCHEMBL1818346 | 0.84 | L3MBTL1 (0.57) | L3MBTL1NR1H4PDK1PDK2PDK3 | |
| SCHEMBL15601887 | 0.83 | HDAC3 (0.72) | L3MBTL1PDK1PDK2PDK3PDK4 | |
| SCHEMBL7276139 | 0.83 | L3MBTL1 (0.59) | L3MBTL1PDK1PDK2PDK3PDK4 | |
| SCHEMBL27673183 | 0.83 | L3MBTL1 (0.59) | L3MBTL1PDK1PDK2PDK3PDK4 | |
| SCHEMBL1819254 | 0.81 | L3MBTL1 (0.58) | L3MBTL1PDK1PDK2PDK3PDK4 | |
| SCHEMBL20981664 | 0.81 | L3MBTL1 (0.82) | L3MBTL1PDK1PDK2PDK3PDK4 | |
| SCHEMBL3982915 | 0.80 | MEN1 (0.56) | L3MBTL1NR1H4MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461134-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2013-06-11 | — | — | US | disclosed |
| US-20110172187-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2011-07-14 | — | — | US | disclosed |
| WO-2011060196-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2011-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172187-A1 | BORON-CONTAINING SMALL MOLECULES | BCL6B, BCL6, BTD | L3MBTL1 270/4885NR1H4 931/4885SELP 719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.